Koers Soligenix Inc OTC Bulletin Board
Aandelen
US8342232084
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2024 * | 708K 653K | Omzet 2025 * | 900K 829K | Marktkapitalisatie | 5,47 mln. 5,04 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -8 mln. -7,37 mln. | Nettowinst (verlies) 2025 * | -9 mln. -8,29 mln. | EV/omzet 2024 * | 7,72 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 6,07 x |
K/w-verhouding 2024 * |
-0,75
x | K/w-verhouding 2025 * |
-0,86
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,93% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 57 | 01-08-06 | |
Jonathan Guarino
DFI | Director of Finance/CFO | 51 | 11-09-19 |
Richard Straube
CTO | Chief Tech/Sci/R&D Officer | 72 | 06-01-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 57 | 01-08-06 | |
Gregg Lapointe
BRD | Director/Board Member | 65 | 01-03-09 |
Robert Rubin
BRD | Director/Board Member | 78 | 01-10-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,63% | 115 mld. | |
+13,17% | 107 mld. | |
-12,76% | 22,31 mld. | |
-3,99% | 21,6 mld. | |
-7,19% | 18,23 mld. | |
-39,93% | 17,62 mld. | |
+6,67% | 14,26 mld. | |
+33,90% | 12,37 mld. | |
-28,60% | 8,28 mld. |
- Beurs
- Aandelen
- Koers SNGX
- Koers